GlassScriptPhysician profile
Jennifer Kolyndra Fields
NPI 1295032746
$1,516.19
in general payments reported to CMS, 2019-2025
17 companies · $108 in 2025
The $108 reported for 2025 was less than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $260 · 2022: $210 · 2023: $484 · 2024: $455 · 2025: $108.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,046.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,046.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $509.50 | 2023-2024 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $173.68 | 2023 | |
| Axsome Therapeutics, INC. | $116.03 | 2024 | Auvelity |
| Alkermes, INC. | $112.83 | 2022 | |
| Avion Pharmaceuticals | $95.31 | 2021 | |
| Evofem Biosciences, INC. | $91.19 | 2021-2022 | |
| Otsuka America Pharmaceutical, INC. | $85.11 | 2023-2025 | Rexulti |
| Organon LLC | $80.36 | 2021-2022 | |
| Daiichi Sankyo INC. | $75.85 | 2021-2022 | |
| E.R. Squibb & Sons, L.L.C. | $41.43 | 2025 | Cobenfy |
| Lundbeck LLC | $34.26 | 2023 | Rexulti |
| Novartis Pharmaceuticals Corporation | $24.28 | 2023 | |
| Neos Therapeutics, LP | $17.84 | 2023 | Adzenys Xr-Odt |
| Vanda Pharmaceuticals INC. | $15.09 | 2023 | Fanapt, Hetlioz |
| Takeda Pharmaceuticals U.S.A., INC. | $15.06 | 2023 | Trintellix |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sage Therapeutics, LLC | $14.55 | 2021 | |
| Tris Pharma INC | $13.82 | 2025 | Dyanavel Xr |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jennifer Fields listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.